ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Valsartan.
Phase of Trial: Phase I
Latest Information Update: 26 May 2010
At a glance
- Drugs Bixalomer; Valsartan
- Indications Diabetic nephropathies; Essential hypertension; Heart failure; Postmyocardial infarction
- Focus Pharmacokinetics
- 26 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 May 2010 New trial record